Accordingly, in models of focal cerebral ischemia–reperfusion injury, the administration of recombinant TSG-6 exerts neuroprotection by promoting Ym1 brain expression while suppressing endoplasmic reticulum stress-related inflammation [48,50]. The gene discussed is TNFAIP6; the disease is Cerebral ischemia.